EFNB2 and neoplasm: For example, ephrinB2 and EphB4 knockouts show defects in arterio-venous patterning [35] and the use of soluble recombinant ephrinB2 or EphB4 proteins can affect migration, adhesion and proliferation of cultured ECs and tumor angiogenesis [21, 36–38].